VITRRO: Versatile Intracranial Tumour Resection Robot
Lead Research Organisation:
King's College London
Department Name: Imaging & Biomedical Engineering
Abstract
Europe has over 87 000 brain and central nervous system cancer patients, which have among the poorest prognoses of all cancer types and result in an annual economic burden of Euro 5.2B. Glioblastoma, the most common primary brain tumour, has a 5-year survival rate of only 10% and is treated by a combination of surgery, radiotherapy, and chemotherapy. Full tumour resection drastically increases the survival rate of patients (200% for high grade gliomas and 160% for low grade gliomas) when compared to subtotal resections. As such, brain tumour surgery aims at the highest rate of resection while optimising safety.
The gold standard for glioblastoma removal is microsurgery, which is highly challenging as it requires a craniotomy, navigation of healthy tissue and bimanual operation in a sensitive and confined space. The complexity of microsurgery can lead to suboptimal resections which, in turn, results in tumour recurrence. Additionally, 5-8% of glioblastoma patients experience postoperative complications, such as permanent motor and language deficits. Microsurgery on intraventricular tumours, a type of cancers that grow in the deep anatomy of the brain, is even less safe and results in complications in 27% of patients.
Alternatively, neuroendoscopic surgery can be a less invasive strategy that can improve safety, yet the approach is hampered by the limited workspace in the brain and only permits single-instrument approaches which results in lower resection rates. Thus, unmet need remains for novel techniques that combine the efficacy of microsurgery and safety of neuroendoscopic surgery. This ERC PoC project aims to technically advance and evaluate the market potential of the Versatile Intracranial Tumour Resection Robot - a highly dexterous, flexible, and small diameter multi-arm continuum robot that can be introduced through a single port (like neuroendoscope) for truly precise, minimally invasive removal of intracranial tumours and other confined space surgeries.
The gold standard for glioblastoma removal is microsurgery, which is highly challenging as it requires a craniotomy, navigation of healthy tissue and bimanual operation in a sensitive and confined space. The complexity of microsurgery can lead to suboptimal resections which, in turn, results in tumour recurrence. Additionally, 5-8% of glioblastoma patients experience postoperative complications, such as permanent motor and language deficits. Microsurgery on intraventricular tumours, a type of cancers that grow in the deep anatomy of the brain, is even less safe and results in complications in 27% of patients.
Alternatively, neuroendoscopic surgery can be a less invasive strategy that can improve safety, yet the approach is hampered by the limited workspace in the brain and only permits single-instrument approaches which results in lower resection rates. Thus, unmet need remains for novel techniques that combine the efficacy of microsurgery and safety of neuroendoscopic surgery. This ERC PoC project aims to technically advance and evaluate the market potential of the Versatile Intracranial Tumour Resection Robot - a highly dexterous, flexible, and small diameter multi-arm continuum robot that can be introduced through a single port (like neuroendoscope) for truly precise, minimally invasive removal of intracranial tumours and other confined space surgeries.
Organisations
People |
ORCID iD |
| Christos Bergeles (Principal Investigator) |
Publications
Huber M
(2024)
LBR-Stack: ROS 2 and Python Integration of KUKA FRI for Med and IIWA Robots
in Journal of Open Source Software
| Description | We have carried out extensive market analysis to understand the potential of neurosurgical robots, especially for intraventricular tumour resection. We have created a pitch deck in support of potential commercialisation opportunities. We have developed a set of requirements to underpin the technical characteristics of flexible neurosurgical robots. |
| Exploitation Route | The software that we have developed is used by at least 4 international universities, and has been started almost 200 times on GitHub. The learnings on clinical requirements have supported an unsuccessful Horizon Europe application on the domain of robotic neurosurgery. |
| Sectors | Healthcare |
| Title | LBR-Stack: ROS 2 and Python Integration of KUKA FRI for Med and IIWA Robots |
| Description | The LBR-Stack is a collection of packages that simplify the usage and extend the capabilities of KUKA's Fast Robot Interface (FRI). It is designed for mission critical hard real-time applications. Supported are the KUKA LBR Med 7/14 and KUKA LBR IIWA 7/14 robots in the Gazebo simulation and for communication with real hardware. |
| Type Of Material | Computer model/algorithm |
| Year Produced | 2024 |
| Provided To Others? | Yes |
| Impact | 190 stars on GitHub, use by at least 4 international universities. |
| URL | https://github.com/lbr-stack/lbr_fri_ros2_stack |
| Description | New Scientist Live 2024 |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Public/other audiences |
| Results and Impact | New Scientist Live 2024, held from October 12-14 at ExCeL London, was a vibrant celebration of science, innovation, and discovery. The event featured over 60 speakers across five stages, interactive exhibits, and hands-on activities. Topics ranged from artificial intelligence and astrophysics to brain health and sustainability. Highlights included Nobel laureate Venki Ramakrishnan's talk on mortality, interactive neuroscience demonstrations, and a live recording of the Dead Planets Society podcast exploring cosmic hypotheticals. The festival also included a dedicated Schools' Day on October 14, engaging thousands of students with STEM activities and career insights. With an attendance of over 25,000 people, the event left visitors inspired by groundbreaking discoveries and the latest advancements in science and technology. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://live.newscientist.com/new-scientist-live |